Pfizer titls to copycats with Aurobindo Deal
March 2009
Hyderabad-based drugmaker
will license and supply 75 generic drugs that address a $200 m market to Pfizer.
After trying it out for
almost a eyar, the world’s biggest drug-maker Pfizer Inc., has decided to turn
copycat in right earnest. And the $50 billion giant will take the help of
Hyderabad-based Aurobindo
Pharma, an established copycat drug-maker, to make
this happen.
The multinational will
license 70 generic drugs and 12 sterile injectibles, inlcuding pencilins and
cephalosporins, which according to industry watechers are valued at over $200
million in sales, from Aurobindo for marketing in the US and Europe.
This is good news for
Aurobindo but many not leave much for Pfizer to smile about, say analysts.
This website is an archive of my articles and interviews apart from the sporadic updates and thoughts that I put out. 
Post a Comment